This Week in PNAS

In PNAS this week, Steven Gygi at Harvard led work that used stable-isotope dilution and high-resolution mass spec to measure kinase activity. His multiplexed assay was able to measure up to 90 site-specific peptide phosphorylation rates at the same time, and he could apply it to a variety of cells and cellular processes, including mitogen stimulation, cell cycle, pharmacological inhibition of pathways, and to a panel of breast cancer cell lines.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.